Antibodies
13 February 2008
Raven Announces Completion of Enrollment in the Phase 1/2a Clinical Trial of RAV12 Therapeutic Antibody for the Treatment of Adenocarcinomas12 February 2008
Sanofi-aventis enters into Antibody Agreements with Dyaxand “Phage Display Technology”12 February 2008
MorphoSys Receives CTA Approval to Initiate Phase 1 Clinical Study for MOR103 Program12 February 2008
Thallion Agrees with FDA on a Path Forward for Shigamabs Development Program in the U.S.11 February 2008
FDA issues Special Protocol Assessment (SPA) for pivotal Phase III trial with CA9-SCAN8 February 2008
Clinical Experience With Peregrine’s Anti-Cancer Agent Bavituximab Presented at Leading Symposium on Anti-Angiogenic Agents6 February 2008
Biovitrum and Symphogen have Successfully Completed Phase I Clinical Trial with Recombinant Polyclonal Antibody6 February 2008
OctoPlus commences United States Phase IIa study with Locteron for the treatment of hepatitis C5 February 2008
FDA Gives Green Light to Lpath’s ASONEP(TM) IND Submittal4 February 2008
Centocor Announces Ustekinumab Biologic License Application Accepted for Filing by FDA4 February 2008
Promising Phase 3 Data for Ustekinumab (Cnto 1275) in Long-Term Improvement of Chronic Plaque Psoriasis2 February 2008
Ustekinumab (CNTO 1275) Phase 3 Data Show Long-Term Improvement Of Chronic Plaque Psoriasis1 February 2008
ImmunoGen, Inc. Earns Milestone with IND Filing for BIIB01531 January 2008
Pooled Phase 3 Study of Nplate(TM) (Romiplostim) in Adult Patients with Chronic ITP Published in the Lancet31 January 2008
TargeGen Announces Initiation of Clinical Trial of JAK2 Inhibitor TG101348 in Myeloproliferative Disease Patients29 January 2008
Viventia Biotech To Explore Strategic Alternatives28 January 2008
Avastin receives broad label extension in Europe for the treatment of patients with metastatic colorectal cancerNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports